InterCure Ltd. (INCR.TA)
ILA 517.4
(-1.45%)
ILA 517.4
(-1.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -61.95 Million ILS | -238.24% |
| 2022 | 44.81 Million ILS | 514.3% |
| 2021 | 7.29 Million ILS | 120.24% |
| 2020 | -36.04 Million ILS | -1102.94% |
| 2019 | -2.99 Million ILS | 76.59% |
| 2018 | -12.79 Million ILS | -143.37% |
| 2017 | -5.25 Million ILS | -2081.27% |
| 2016 | 265.41 Thousand ILS | 114.14% |
| 2015 | -1.87 Million ILS | 50.49% |
| 2014 | -3.79 Million ILS | 42.59% |
| 2013 | -6.6 Million ILS | -115.21% |
| 2012 | 43.44 Million ILS | 738.72% |
| 2011 | -6.8 Million ILS | 45.86% |
| 2010 | -12.56 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 716.5 Thousand ILS | 102.14% |
| 2024 Q2 | 716.5 Thousand ILS | 0.0% |
| 2023 Q4 | -33.52 Million ILS | 0.0% |
| 2023 FY | -61.95 Million ILS | -238.24% |
| 2023 Q1 | 92 Thousand ILS | -98.25% |
| 2023 Q2 | 4.88 Million ILS | 5207.61% |
| 2023 Q3 | -33.52 Million ILS | -786.63% |
| 2022 Q3 | 7.25 Million ILS | -53.6% |
| 2022 Q4 | 5.26 Million ILS | -27.43% |
| 2022 FY | 44.81 Million ILS | 514.3% |
| 2022 Q1 | 13.37 Million ILS | 535.78% |
| 2022 Q2 | 15.63 Million ILS | 16.93% |
| 2021 Q2 | 6.19 Million ILS | 92.72% |
| 2021 Q4 | -3.06 Million ILS | -86.68% |
| 2021 FY | 7.29 Million ILS | 120.24% |
| 2021 Q1 | 3.21 Million ILS | -65.16% |
| 2021 Q3 | -1.64 Million ILS | -126.55% |
| 2020 FY | -36.04 Million ILS | -1102.94% |
| 2020 Q2 | -978 Thousand ILS | 97.93% |
| 2020 Q3 | 1.73 Million ILS | 277.3% |
| 2020 Q1 | -47.2 Million ILS | -243.46% |
| 2020 Q4 | 9.22 Million ILS | 431.83% |
| 2019 Q3 | -15.5 Million ILS | -34.38% |
| 2019 Q1 | 37.79 Million ILS | 1047.77% |
| 2019 Q2 | -11.54 Million ILS | -130.53% |
| 2019 FY | -2.99 Million ILS | 76.59% |
| 2019 Q4 | -13.74 Million ILS | 11.37% |
| 2018 Q4 | -3.98 Million ILS | 0.0% |
| 2018 Q2 | -2.41 Million ILS | 0.0% |
| 2018 FY | -12.79 Million ILS | -143.37% |
| 2018 Q1 | -2.41 Million ILS | -56.36% |
| 2018 Q3 | -3.98 Million ILS | -65.41% |
| 2017 Q4 | -1.54 Million ILS | 0.0% |
| 2017 FY | -5.25 Million ILS | -2081.27% |
| 2017 Q3 | -1.54 Million ILS | -28.13% |
| 2017 Q2 | -1.2 Million ILS | 3.69% |
| 2017 Q1 | -1.24 Million ILS | -512.85% |
| 2016 FY | 265.41 Thousand ILS | 114.14% |
| 2016 Q1 | 1.16 Million ILS | 229.63% |
| 2016 Q2 | -902.28 Thousand ILS | -177.74% |
| 2016 Q3 | 195.23 Thousand ILS | 121.64% |
| 2016 Q4 | -203.89 Thousand ILS | -204.44% |
| 2015 Q2 | 170.08 Thousand ILS | 166.13% |
| 2015 Q4 | -895.38 Thousand ILS | 0.92% |
| 2015 Q3 | -903.69 Thousand ILS | -631.31% |
| 2015 Q1 | -257.19 Thousand ILS | 58.72% |
| 2015 FY | -1.87 Million ILS | 50.49% |
| 2014 Q2 | -1.08 Million ILS | -103.11% |
| 2014 Q1 | -535.77 Thousand ILS | 65.36% |
| 2014 FY | -3.79 Million ILS | 42.59% |
| 2014 Q4 | -623.11 Thousand ILS | 56.65% |
| 2014 Q3 | -1.43 Million ILS | -32.09% |
| 2013 Q1 | -1.31 Million ILS | 65.52% |
| 2013 Q2 | -1.53 Million ILS | -16.49% |
| 2013 FY | -6.6 Million ILS | -115.21% |
| 2013 Q3 | -2.27 Million ILS | -48.57% |
| 2013 Q4 | -1.54 Million ILS | 32.05% |
| 2012 Q1 | -3.32 Million ILS | 0.0% |
| 2012 Q3 | 51.15 Million ILS | 13859.91% |
| 2012 FY | 43.44 Million ILS | 738.72% |
| 2012 Q4 | -3.81 Million ILS | -107.46% |
| 2012 Q2 | -371.74 Thousand ILS | 88.81% |
| 2011 FY | -6.8 Million ILS | 45.86% |
| 2010 FY | -12.56 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cannabotech LTD | -16.12 Million ILA | -284.313% |